On Thursday, Teladoc Health received a positive adjustment to its Relative Strength (RS) Rating, from 89 to 92.
This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
History reveals that the market's biggest winners often have an RS Rating of at least 80 as they launch their largest runs.
Looking For The Best Stocks To Buy And Watch? Start Here
Teladoc Health is not currently showing a potential buy point. See if the stock goes on to form a base that could kick off a new price move.
The company posted negative growth for both sales and earnings last quarter. The company is expected to release its next quarterly numbers on or around Feb. 26.
The company holds the No. 8 rank among its peers in the Computer Software-Medical industry group. Doximity, Waystar Holding and Veeva Systems Cl A are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
